M&A Deal Summary |
|
|---|---|
| Date | 2019-11-21 |
| Target | FUJIFILM Toyama Chemical Co. s Clinical Stage Antifungal Program |
| Sector | Life Science |
| Buyer(s) | Appili Therapeutics |
| Sellers(s) | FUJIFILM Toyama Chemical Co. |
| Deal Type | Divestiture |
SEARCH BY
Appili Therapeutics is a biopharmaceutical company focused on anti-infective drug development. Appili provides drug development programs for unmet patient needs across a broad spectrum of infectious diseases. Appili Therapeutics was founded in 2015 and is based in Halifax, Canada.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: Japan M&A | 1 of 1 |
| Year: 2019 M&A | 1 of 1 |
FUJIFILM Toyama Chemical Co., Ltd. is a provider of research, development, manufacture, and sales of small molecule pharmaceutical products. FUJIFILM Toyama Chemical Co., Ltd. was founded in 1968 and is based in Tokyo, Japan.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: Japan M&A | 1 of 1 |
| Year: 2019 M&A | 1 of 1 |
